Disease management
The diabetes-focused company provides endocrinologists with tools to implement value-based care, collect data, and improve revenue growth and patient engagement.
CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.
Also, mental health platform Amaha, formerly InnerHour, has received $6 million in additional Series A funding for its expansion.
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
The company will use the funds to expand its commercial efforts and seek additional clinical validation of its tech-enabled offering.
More hospitals are coming into the fold in the coming months.
Also, Canon Medical and Olympus are collaborating on endoscopic ultrasonography.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
Also, researchers from India have developed an AI model that can detect indications of carpal tunnel syndrome in ultrasound videos.